Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland

ABSTRACT Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity against strains of N. meningitidis, reg...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Robert M. Mulhall, Desiree Bennett, Robert Cunney, Ray Borrow, Jay Lucidarme, Jamie Findlow, Keith A. Jolley, James Bray, Martin C. J. Maiden, Monica Moschioni, Laura Serino, Maria Stella, Duccio Medini
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Society for Microbiology 2018-08-01
Serie:	mSphere
Ämnen:	4CMenB MATS MenB NHBA NadA Neisseria meningitidis
Länkar:	https://journals.asm.org/doi/10.1128/mSphere.00196-18
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!